TCL Archive FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions. June 2, 2006
TCL Archive In brief: Cancer Investment “Drop In The Bucket,” OMB Is The “Second Greatest Kill,” Pepper Says August 10, 1979
TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
